Skip to main content
. 2017 Jul 17;12:120. doi: 10.1186/s13014-017-0856-2

Table 3.

Prognostic factors of progression free survival and overall survival

Progression-free survival Overall survival
Univariate Cox model Multivariate Cox Model Univariate Cox model Multivariate Cox Model
Variables HR 95% CI HR 95% CI HR 95% CI HR 95% CI
FIGO
IIB 1.00 1.00
IIIB 1.22 0.72–2.07 1.03 0.57–1.88 2.03 0.87–4.73 1.69 0.64–4.53
Differentiation degree
Well 1.00 1.00
Moderately 2.35 0.72–7.69 2.89 0.85–9.86 1.65 0.38–7.05 2.42 0.56–10.5
Poorly 1.78 0.45–7.03 1.83 0.46–7.50 0.92 0.15–0.56 0.95 0.15–5.70
Treatment type
Exclusive EBRT + Brachytherapy 1.00 1.00
Chemo-Radiotherapy + Brachytherapy 0.58 0.35–0.95 0.57 0.32–1.00 0.38 0.18–0.80 0.36 0.16–0.82
Tumor protein strong expression
SURVIVIN 1.02 0.46–2.28 1.37 0.51–3.67 1.35 0.40–4.47 1.80 0.51–6.46
IGF1R-β 1.53 0.81–2.89 1.81 0.87–3.76 2.7 0.94–7.73 5.38 1.59–18.3
IGF1R-α 1.07 0.57–1.98 1.08 0.54–2.17 1.58 0.60–4.12 2.06 0.70–6.12
GLUT-1 0.99 0.54–1.83 1.04 0.55–1.98 1.66 0.77–3.55 2.22 0.99–5.04
HIF-1α 1.46 0.79–2.70 1.56 0.80–3.05 0.92 0.42–2.00 0.94 0.41–2.17
CAIX 0.52 0.20–1.32 0.50 0.20–0.30 0.53 0.16–1.77 0.58 0.17–2.02
Impact of anemia
Hb 2.20 1.33–3.65 1.78 1.00–3.15 2.11 1.04–4.33 2.01 0.92–4.40

HR Hazard ratio, CI Confidence interval, FIGO International Federation of Gynecology and Obstetrics, EBRT External beam radiotherapy